JTFM and BB- I agree that the CVRs ever paying out is highly unlikely. I also agree that Intrinsa patches advancing with our safety data is a real possibility. The transmission of testosterone to others was a big factor discussed early on (even though the dosage is ridiculously small) and the patch will be seen as safer. Intrinsa also has an actual customer history elsewhere.
News 
Market Data 
Discover 
AI
